Findings from a new study indicate a potential association between respiratory syncytial virus (RSV) infection and the later development of type 2 diabetes mellitus (T2DM). However, ...

GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...

The American Medical Association and a leading public health research group focused on vaccines are teaming up to create a ...

There were 6 COVID outbreaks last week (2 the week before), with 3 in Long-Term Care Facilities and 1 in schools. Outbreaks ...

The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine ...

TidalHealth is lifting most masking requirements as flu, RSV and COVID cases decline, with some clinical settings still requiring masks.

Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER visits for RSV are “high” or “very high” in more than half of New Jersey ...

Health officials are urging residents to take preventive steps such as vaccination, handwashing and staying home when sick.

Norway, Denmark, and other countries with fewer childhood vaccines have another thing in common: paid parental leave.

(Alliance News) - GSK PLC on Tuesday said its respiratory syncytial virus vaccine Arexvy has been accepted for review by China's Center for Drug Evaluation for adults aged 60 and over. The ...